CD86 and lung carcinoma: Cultures with lung cancer (A549), pancreatic cancer (PANC–1), and breast cancer (MDA-MB-231) were established and revealed similar results to the murine cultures regarding CD11c+/CD86+ cell populations (Figures 4F–H).